1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co
XNYS: LLY

Eli Lilly Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
903.99 -1.04 (-0.11%)
44.92% Gain from 52W Low
2.8M
XNYS Volume

XNYS 16 Apr, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Acquisition
Eli Lilly to buy pre-clinical biotech CrossBridge for up to $300 mn to expand its cancer pipeline See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
33.2 / 100
Momentum Score
Technically Neutral
51.7 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
1,210
1Yr Price target upside is 34%
29 analysts

10

S

6

W

5

O

1

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..